Healthcare Realty Trust (NYSE:HR) Issues FY 2024 Earnings Guidance

Healthcare Realty Trust (NYSE:HRGet Free Report) issued an update on its FY 2024 earnings guidance on Saturday morning. The company provided earnings per share (EPS) guidance of 1.530-1.580 for the period, compared to the consensus estimate of 1.550. The company issued revenue guidance of -.

Healthcare Realty Trust Trading Up 0.2 %

NYSE HR opened at $17.94 on Friday. The business has a fifty day simple moving average of $17.81 and a 200 day simple moving average of $16.06. Healthcare Realty Trust has a 12 month low of $12.77 and a 12 month high of $18.90. The firm has a market capitalization of $6.79 billion, a P/E ratio of -13.49 and a beta of 0.91.

Healthcare Realty Trust (NYSE:HRGet Free Report) last announced its earnings results on Friday, August 2nd. The real estate investment trust reported ($0.39) EPS for the quarter, missing the consensus estimate of $0.38 by ($0.77). Healthcare Realty Trust had a negative net margin of 42.79% and a negative return on equity of 8.50%. The firm had revenue of $316.30 million during the quarter, compared to analysts’ expectations of $317.90 million. During the same quarter in the prior year, the company earned $0.39 EPS. The business’s revenue for the quarter was down 6.4% on a year-over-year basis. As a group, sell-side analysts predict that Healthcare Realty Trust will post 1.56 EPS for the current fiscal year.

Healthcare Realty Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Monday, August 12th were issued a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 6.91%. The ex-dividend date was Monday, August 12th. Healthcare Realty Trust’s dividend payout ratio is presently -93.23%.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Wedbush boosted their price objective on Healthcare Realty Trust from $15.00 to $18.00 and gave the stock a neutral rating in a research report on Monday, August 5th. Wells Fargo & Company cut Healthcare Realty Trust from an equal weight rating to an underweight rating and lowered their target price for the stock from $17.00 to $16.00 in a research note on Tuesday, July 30th. Finally, Scotiabank increased their price target on shares of Healthcare Realty Trust from $17.00 to $18.00 and gave the company a sector perform rating in a research report on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of Hold and an average target price of $17.00.

View Our Latest Analysis on Healthcare Realty Trust

Insider Activity at Healthcare Realty Trust

In other Healthcare Realty Trust news, Director John Knox Singleton bought 6,500 shares of the business’s stock in a transaction on Thursday, September 5th. The stock was purchased at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the transaction, the director now directly owns 57,082 shares of the company’s stock, valued at $1,041,175.68. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Thomas N. Bohjalian purchased 9,000 shares of the business’s stock in a transaction dated Monday, August 12th. The stock was purchased at an average cost of $17.39 per share, with a total value of $156,510.00. Following the completion of the acquisition, the director now directly owns 22,252 shares of the company’s stock, valued at $386,962.28. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John Knox Singleton acquired 6,500 shares of the firm’s stock in a transaction that occurred on Thursday, September 5th. The shares were bought at an average price of $18.24 per share, for a total transaction of $118,560.00. Following the completion of the purchase, the director now owns 57,082 shares in the company, valued at approximately $1,041,175.68. The disclosure for this purchase can be found here. In the last three months, insiders have bought 15,728 shares of company stock worth $279,069. Company insiders own 0.56% of the company’s stock.

About Healthcare Realty Trust

(Get Free Report)

Healthcare Realty (NYSE: HR) is a real estate investment trust (REIT) that owns and operates medical outpatient buildings primarily located around market-leading hospital campuses. The Company selectively grows its portfolio through property acquisition and development. As the first and largest REIT to specialize in medical outpatient buildings, Healthcare Realty's portfolio includes more than 700 properties totaling over 40 million square feet concentrated in 15 growth markets.

Featured Articles

Earnings History and Estimates for Healthcare Realty Trust (NYSE:HR)

Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.